Gene Editing investors worldwide.

Gene Editing investors

Fliar publishes 1 investor page for Gene Editing. That is 1 investor list. The list with the most capital behind it is Gene Editing investors in Cambridge ($15B across the rounds it covers).

Most of them are in Cambridge (1) and United States (1).

People browsing Gene Editing also open Gene Therapy, Gastroenterology, Chemicals Tech, Rare Metabolic Diseases Drugs, Microbiome Therapeutics and Immunotherapeutic Vaccines.